Aspirin and post-prostatectomy haemorrhage

Area of Science:

• Urology
• Pharmacology
• Hematology

Background:

• Transurethral prostatectomy (TURP) is a common surgical procedure for benign prostatic hyperplasia.
• Post-operative hemorrhage is a known complication of TURP, sometimes requiring intervention.
• The role of common medications in exacerbating surgical bleeding risks is an area of ongoing research.

Purpose of the Study:

• To investigate the potential association between aspirin ingestion and severe hemorrhage following transurethral prostatectomy.
• To elucidate the pharmacological mechanisms underlying this potential association.
• To provide clinical recommendations for surgeons managing patients on antiplatelet therapy.

Main Methods:

• Retrospective analysis of patient data undergoing transurethral prostatectomy.
• Correlation of severe hemorrhage events with pre-operative medication history, specifically aspirin use.
• Review of platelet aggregation studies and literature on NSAID effects.

Main Results:

• A documented relationship between severe hemorrhage and aspirin ingestion was observed.
• Aspirin's anti-platelet effects are identified as the likely mechanism contributing to increased bleeding.
• Potential risks associated with other non-steroidal anti-inflammatory agents (NSAIDs) were also considered.

Conclusions:

• Patients undergoing transurethral prostatectomy who have ingested aspirin may be at increased risk of severe hemorrhage.
• Caution is advised when performing surgery on patients taking aspirin or potentially other NSAIDs due to their anti-platelet effects.
• Surgeons should carefully consider patient medication history, particularly NSAID use, prior to prostatectomy.